To address whether IDH1 mutation is involved in antiviral immunity, we first analyzed the publicly available transcriptomic datasets from 3 independent clinical cohorts, including GEO and TCGA, and found that IFN signaling pathways were downregulated in IDH1mut gliomas versus IDH1wt gliomas (Fig. 1a, b). Here, IDH1 is linked to glioma.